<PAGE> 1
As filed with the Securities and Exchange Commission on April 11, 1997
Registration Statement No. 333-03879
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
POST EFFECTIVE AMENDMENT NO. 1
FORM S-3
Registration Statement Under The Securities Act of 1933
WANG LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
Delaware 7372 04-2192707
- ------------------------------ --------------------------- -------------------
(State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer
incorporation or organization) Classification Code Number) Identification No.)
</TABLE>
600 TECHNOLOGY PARK DRIVE
BILLERICA, MASSACHUSETTS 01821
(508) 967-5000
------------------------------
(Address, including Zip Code, and Telephone Number, Including Area Code, of
Registrant's Principal Executive Offices)
ALBERT A. NOTINI, ESQ.
SENIOR VICE PRESIDENT,
GENERAL COUNSEL AND SECRETARY
WANG LABORATORIES, INC.
600 TECHNOLOGY PARK DRIVE
BILLERICA, MASSACHUSETTS 01821
(508) 967-5000
------------------------------
(Name, Address, Including Zip Code, and Telephone Number,
Including Area Code, of Agent for Service)
Copies to:
PATRICK J. RONDEAU, ESQ.
HALE AND DORR LLP
60 STATE STREET
BOSTON, MASSACHUSETTS 02109
(617) 526-6000
Approximate date of commencement of proposed sale to the public: As soon as
practicable after the effective date hereof.
If the only securities being registered on this form are being offered pursuant
to dividend or interest reinvestment plans, please check the following box. | |
If any of the securities being registered on this form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. | |
<PAGE> 2
If this form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registrations statement number of the earlier effective
registration statement for the same offering. | |
If this form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. | |
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. | |
2
<PAGE> 3
This post-effective amendment No. 1 to the Registration Statement to Form
S-3, as filed with the Commission on May 16, 1996 (the "Registration Statement")
is being filed for the purpose of deregistering all of the shares of Common
Stock, $0.01 par value per share, of Wang Laboratories, Inc. registered pursuant
to the Registration Statement that have not yet been sold thereunder and
terminating the Registration Statement.
3
<PAGE> 4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused this
Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Billerica, Commonwealth of Massachusetts this
10th day of April, 1997.
WANG LABORATORIES, INC.
By: /s/ Franklyn A. Caine
-------------------------------
Franklyn A. Caine
Executive Vice President and
Chief Financial Officer
SIGNATURES AND POWER OF ATTORNEY
Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons on this 10th
day of April, 1997, in the capacities indicated:
Signature Title Date
/s/ Joseph M. Tucci* Chairman of the Board, Chief
- -------------------------- Executive Officer and Director
Joseph M. Tucci (Principal Executive Officer)
/s/ Franklyn A. Caine Executive Vice President and April 10, 1997
- -------------------------- Chief Financial Officer
Franklyn A. Caine (Principal Financial Officer and
Principal Accounting Officer)
/s/ David A. Boucher* Director
- --------------------------
David A. Boucher
/s/ Michael W. Brown* Director
- --------------------------
Michael W. Brown
/s/ Marcia J. Hooper* Director
- --------------------------
Marcia J. Hooper
/s/ Joseph J. Kroger* Director
- --------------------------
Joseph J. Kroger
/s/ Raymond C. Kurzweil* Director
- --------------------------
Raymond C. Kurzweil
/s/ Axel J. Leblois* Director
- --------------------------
Axel J. Leblois
/s/ Frederick A. Wang* Director
- --------------------------
Frederick A. Wang
*By: /s/ Franklyn A. Caine
- --------------------------
Franklyn A. Caine, Attorney-in-Fact
4
